(Q113886725)

English

Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema

clinical trial

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

short name

DANTE (English)

0 references

title

Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema: The Multicenter DANTE Study (English)

0 references

medical condition

macular degeneration

0 references

start time

22 June 2020

0 references

end time

31 December 2021

0 references

number of participants

49

0 references

research intervention

(RS)-cyclophosphamide

0 references

non-steroidal anti-inflammatory drug

0 references

antiemetic

0 references

peripheral nervous system agent

0 references

gastrointestinal agent

0 references

hormones, hormone substitutes, and hormone antagonists

0 references

hormonal antineoplastic agent

0 references

alkylating antineoplastic agent

0 references

clinical trial phase

phase IV clinical trial

0 references

research subject recruitment status

unknown

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT04448496

0 references

(Q113886725)

Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)